Marshall Wace
ONCE

Marshall Wace’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Marshall Wace’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-187,596
Closed -$18.2M – 2277
2019
Q3 		$18.2M Buy
187,596
+128,657
+218% +$12.9M 0.14% 169
2019
Q2 		$6.03M Buy
58,939
+8,469
+17% +$914K 0.05% 425
2019
Q1 		$5.75M Buy
50,470
+47,485
+1,591% +$3.49M 0.05% 426
2018
Q4 		$117K Sell
2,985
-38,323
-93% -$1.66M ﹤0.01% 1344
2018
Q3 		$2.25M Buy
+41,308
New +$2.82M 0.02% 655
2018
Q1 		– Sell
-6,515
Closed -$335K – 685
2017
Q4 		$335K Sell
6,515
-9,901
-60% -$711K 0.01% 340
2017
Q3 		$1.46M Buy
+16,416
New +$1.25M 0.07% 191
2017
Q1 		– Sell
-94,927
Closed -$4.74M – 891
2016
Q4 		$4.74M Buy
+94,927
New +$5.09M 0.03% 487
2016
Q2 		– Sell
-13,738
Closed -$405K – 1254
2016
Q1 		$405K Buy
+13,738
New +$433K ﹤0.01% 884

Marshall Wace's ONCE Position: Q4 2019 in Review

Marshall Wace sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 187,596 shares — an estimated $18.2M sold.

Marshall Wace first reported a position in ONCE in Q1 2016 and held it in 9 quarters. The position peaked at $18.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Marshall Wace reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace sold 187,596 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $18.2M.
  • Marshall Wace first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 9 quarters.
  • Marshall Wace's Spark Therapeutics, Inc. Common Stock position peaked at $18.2M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.